Skip to content

Treatment of Adult Men with Metastatic Hormone-sensitive Prostate Cancer in Combination with Androgen Deprivation Therapy

Treatment of Adult Men with Metastatic Hormone-sensitive Prostate Cancer in Combination with Androgen Deprivation Therapy can cause discomfort and affect wellbeing. The catalogue here covers Enzalutamide and related products that may be prescribed to manage it. Products containing Enzalutamide feature in this group.

Xtandi

Enzalutamide

40mg

Blocks androgen receptors and inhibits androgen receptor signalling to slow prostate cancer growth and delay disease progression in adult men with prostate cancer.

From$19.02/ capsuleView

Review product labelling and speak with a healthcare professional before treatment decisions.